Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts
May 17, 2021 06:10 ET | Source: Zomedica Corp. Zomedica Corp. Ann Arbor, Michigan, UNITED STATES
Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities
ANN ARBOR, Mich., May 17, 2021 (GLOBE NEWSWIRE) Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that it has hired a Vice President Business Development to lead its acquisition and licensing efforts.
“As disclosed in our first quarter financials, Zomedica had a cash and cash equivalents balance of approximately $276.6 million as of March 31, 2021,” commented Robert Cohen, Chief Executive Officer of Zomedica. “To complement our TRUFORMA
Zomedica Announces First Commercial Sale of Its Truforma® Platform
March 16, 2021 06:00 ET | Source: Zomedica Corp. Zomedica Corp. Ann Arbor, Michigan, UNITED STATES
ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA
® and officially entered commercialization.
“This is a momentous day for Zomedica, our shareholders, the veterinarians we serve, and the companion animals in their care. I would like to express my deepest gratitude to the many people at Zomedica who dedicated the past two years of their lives to achieving this critical milestone,” commented Robert Cohen, Zomedica’s Chief Executive Officer. “It is a credit to both our employees and to the stellar team with whom we have worked at
Reader Advisory
Except for statements of historical fact, this news release contains certain forward-looking information or “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as plan , expect , project , intend , believe , anticipate , estimate and other similar words, or statements that certain events or conditions may or will occur and include statements relating to our expectations regarding future results. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.